Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aritra Gangopadhyay

AbbVie Stock: Is ABBV Outperforming the Healthcare Sector?

North Chicago, Illinois-based AbbVie Inc. (ABBV) is a research-based biopharmaceutical company that engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. Valued at a market cap of $386.3 billion, the company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta to treat blood cancers, among others.

Companies with a market capitalization of $200 billion or more are typically referred to as "mega-cap stocks." ABBV fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the general drug manufacturers industry.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.